My husband has a chance for a cure.  He is patient #3 in a first in human clinical trial for kidney cancer and I’ll be sharing part of his journey here.

His name is Ralph Knapp, he’s 57 and was diagnosed 4.5 years ago with stage IV Kidney Cancer.  This will be his 8th different treatment and 4th clinical trial.  He has been treated in 3 different NCI – Designated Cancer Centers around the country.  To say he is a fighter is an understatement.

Very few patients with advanced kidney cancer have long term durable responses. None of the drug options currently available to Ralph offer a hope for a cure and little hope for stability.  The past 4.5 years we have chased one treatment after another and seen Ralph’s cancer recur and progress.  We are now chasing a cure.

Somehow I knew we would eventually end up at the largest hospital devoted solely to clinical investigation in the world – The National Institutes of Health or NIH.

The HERV-E trial is a gene transfer therapy trial, in which a patient’s own T-Cells are modified genetically and reintroduced into the body.  This is the first time they have investigated this therapy in kidney cancer.  Also literally a first in human clinical trial since mice don’t have the genetic makeup for this study.  Ralph was approved for the trial based on DNA testing that was done through saliva.  For more scientific analysis of the trial – click HERE.

This is a phenomenal opportunity for Ralph.   He is one of the lucky 15-18% of Caucasians that have this genetic marker and a chance for a cure.  Stay tuned.

 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H activities with a strong...

SPRING ADVOCACY DAYS 2024 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H activities with a strong...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER
kidney cancer and the military

KIDNEY CANCER & THE MILITARY

CLINICAL TRIALS →

IMMUNOTHERAPY →

RESEARCH UPDATES →

SURVIVORSHIP →

OPTIMIZING YOUR KIDNEY HEALTH →

HANDLING HOLIDAYS WITH CANCER →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Dr. Yousef Zakharia: “I Believe in Teamwork”

Dr. Yousef Zakharia: “I Believe in Teamwork”

For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at NCI-designated centers, as well as his...

SUPPORT OUR WORK →

ROCK THE RUN 2023 →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News